Generic Corporate Development

To support its business strategies, the Company continually evaluates acquisition opportunities to strengthen its product portfolio and grow its generic business. Barr regularly evaluates opportunities such as strategic product acquisitions, new technology arrangements including new technology platforms, and corporate mergers and acquisitions.

Generic Business Overview
Barr Laboratories, Inc.
PLIVA d.d.
Generic Product Development

•	Patent Challenges
•	Generic Technology Platforms
•	Generic Corporate Development

Generic Industry Links
Clinical Trials